Trademark: 79238591
Word
NMD NEUROMUSCULAR DISORDERS
Status Date
Tuesday, July 23, 2019
Registration Number
5809159
Registration Date
Tuesday, July 23, 2019
Filing Date
Friday, May 18, 2018
Published for Opposition
Tuesday, May 7, 2019
5 Chemical-pharmaceutical preparations for the treatment of rare and genetic diseases; chemical-pharmaceutical preparations for the treatment of neurodegenerative diseases; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders; chemical-pharmaceutical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by compromised skeletal muscle excitability; diagnostic preparations for medical purposes; reagents for medical purposes [ and for research ] ; preparations for analysis for medical [ and research ] purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; pharmaceutical and medical preparations for acute hospital care, namely, chemical-pharmaceutical preparations for the reversal of neuromuscular blockade, chemical-pharmaceutical preparations for the treatment of intensive care unit acquired muscle weakness, chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by infections
42 Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care
The mark consists of the letters "NMD" in dark grey with a green diamond over the letter "M" followed by the wording "NEUROMUSCULAR DISORDERS" in light grey with "NEUROMUSCULAR" above the word "DISORDERS" and with a vertical grey line between "NMD" and "NEUROMUSCULAR DISORDERS".
In the statement, in the heading, " International Class 5" is corrected per the restriction and the fnote dated 11/14/2019.
The color(s) dark grey, light grey, and green is/are claimed as a feature of the mark.
"NEUROMUSCULAR DISORDERS"
Aug 16, 2018
Sn Assigned For Sect 66a Appl From Ib
Aug 20, 2018
New Application Office Supplied Data Entered
Aug 24, 2018
Application Filing Receipt Mailed
Sep 10, 2018
Assigned To Examiner
Sep 17, 2018
Non-Final Action Written
Sep 18, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Sep 21, 2018
Refusal Processed By Mpu
Sep 21, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Oct 13, 2018
Refusal Processed By Ib
Mar 4, 2019
Teas Response To Office Action Received
Mar 4, 2019
Correspondence Received In Law Office
Mar 5, 2019
Teas/Email Correspondence Entered
Mar 18, 2019
Examiners Amendment -Written
Mar 18, 2019
Examiners Amendment E-Mailed
Mar 18, 2019
Notification Of Examiners Amendment E-Mailed
Mar 18, 2019
Examiner's Amendment Entered
Apr 17, 2019
Notification Of Possible Opposition Sent To Ib
Mar 18, 2019
Approved For Pub - Principal Register
Apr 17, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 17, 2019
Notification Of Notice Of Publication E-Mailed
Apr 30, 2019
Teas Change Of Correspondence Received
May 3, 2019
Notification Processed By Ib
May 7, 2019
Published For Opposition
May 7, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 23, 2019
Registered-Principal Register
Aug 23, 2019
Limitation Of Goods Received From Ib
Oct 23, 2019
Final Disposition Notice Created, To Be Sent To Ib
Nov 14, 2019
Final Disposition Processed
Nov 14, 2019
Limitation From The Ib Examined And Entered
Nov 14, 2019
Final Disposition Notice Sent To Ib
Nov 21, 2019
Case Assigned To Post Registration Paralegal
Nov 21, 2019
Correction Under Section 7 - Processed
Sep 9, 2023
Change Of Name/Address Rec'd From Ib
Jul 23, 2024
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Aug 29, 2020
Invalidation Reviewed - No Action Required By Office
Dec 6, 2019
Final Decision Transaction Processed By Ib
Jul 26, 2020
Partial Invalidation Of Reg Ext Protection Created
Trademark Alertz updated from USPTO on 2030-01-24
